Pulse Brain · Growing Health Evidence Index
Peer-reviewed

Identification of risk loci for primary aldosteronism in genome-wide association studies

Édith Le Floch, Teresa Cosentino, Casper K. Larsen, Felix Beuschlein, Martín Reincke, Laurence Amar, Gian Paolo Rossi, Kelly De Sousa, Stéphanie Baron, Sophie Chantalat, Benjamin Saintpierre, Livia Lenzini, Arthur Frouin, Isabelle Giscos-Douriez, Matthis Ferey, Alaa B Abdellatif, Tchao Méatchi, Jean‐Philippe Empana, Xavier Jouven, Christian Gieger, Mélanie Waldenberger, Annette Peters, Daniele Cusi, Erika Salvi, Pierre Meneton, Mathilde Touvier, Mélanie Deschasaux, Nathalie Druesne‐Pecollo, Sheerazed Boulkroun, Fábio L. Fernandes‐Rosa, Jean‐François Deleuze, Xavier Jeunemaı̂tre, Maria‐Christina Zennaro

Nature Communications · 2022

Read source ↗ All evidence

Summary

Primary aldosteronism affects up to 10% of hypertensive patients and is responsible for treatment resistance and increased cardiovascular risk. Here we perform a genome-wide association study in a discovery cohort of 562 cases and 950 controls and identify three main loci on chromosomes 1, 13 and X; associations on chromosome 1 and 13 are replicated in a second cohort and confirmed by a meta-analysis involving 1162 cases and 3296 controls. The association on chromosome 13 is specific to men and stronger in bilateral adrenal hyperplasia than aldosterone producing adenoma. Candidate genes located within the two loci, CASZ1 and RXFP2, are expressed in human and mouse adrenals in different cell clusters. Their overexpression in adrenocortical cells suppresses mineralocorticoid output under bas

Source type
Peer-reviewed study
DOI
10.1038/s41467-022-32896-8
Catalogue ID
SNmoj1xvqt-2gsyak
Pulse AI · ask about this record

Dig deeper with Pulse AI.

Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.